Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Japanese Ministry Of Health Approves Rasilez(R), A First-in-class Direct Renin Inhibitor (DRI), For The Treatment Of High Blood Pressure
Rasilez® (aliskiren), the first new type of high blood pressure medicine in more than a decade, has been approved for use in Japan. Rasilez directly inhibits renin9, an enzyme that triggers a process leading to high blood pressure and organ damage. The Ministry of Health, Labour and Welfare (MHLW) in Japan approved Rasilez for the treatment of high blood pressure alone or in combination with other high blood pressure medicines.
generic viagra online
Swine Flu Expected To Continue Through The Summer, US
Health officials said on Thursday that it looks like the novel H1N1 swine flu virus will continue to spread in the US through the summer months,
News of the day
Youths Use Drink Labels To Choose Strongest Drink At Lowest Cost, Australia
Contrary to the industry"s position that visible drink labels will promote responsible drinking, young people are, instead, using these visible standard drink labels to increase or even maximize the amount of alcohol they consume at the lowest cost possible.
Diagnostics

Risk Of Death In The Very Elderly Increased By Anemia

Anemia in very elderly people aged 85 and older appears to be associated with an increased risk of death, according to a new study in CMAJ (Canadian Medical Association Journal). The study was part of the Leiden 85-plus study that looked at 562 people aged 85 years in the Netherlands and followed them until age 90. Twenty-seven per cent of participants had anemia at the start of the study (prevalent anemia) and, in the follow up period, incident anemia developed in 24% of the people without anemia at the start of the study. Anemia in elderly people is generally associated with increased death as well as decreased mobility, cognitive impairment, depression, falls and fractures, hospital admission and diminished quality of life. It can significantly affect health care needs and costs in ageing Western societies. In the study group, the risk of death was similar among men and women, and among people in long-term care facilities and in the community. "We found a strong, independent association between prevalent anemia in participants at age 85 years and risk of death," write Ms. Wendy den Elzen of the Leiden University Medical Center and coauthors, confirming results of previous studies of people in the Netherlands and North America. "We found that incident anemia in participants beyond the age of 85 years had an even stronger impact on mortality than prevalent anemia at age 85." After adjusting for other illnesses, the negative effect of anemia on cognitive ability and physical function was neutralized. The authors conclude that the associated functional decline appears to be mainly attributed to comorbid illnesses. In a related commentary, Dr. Mark Clarfield of Ben-Gurion University and Dr. Ora Paltiel of Hadassah-Hebrew University in Israel write "for unexplained anemia in elderly patients, we may never be able to disentangle whether the underlying cause or the anemia is responsible for death." They caution that proof is needed that routinely correcting unexplained anemia is more beneficial than harmful. Kim Barnhardt Canadian Medical Association Journal


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009